Nerve-sparing surgery and post-surgical sexual function: news from Kyoto

According to a report from Prof. Thomas Aherling on the UroToday web site, there were three interesting presentations related to nerve-sparing surgery at the recent World Conference of Endourology and SWL, in Kyoto Japan. … READ MORE …

VED + taldalafil helps with return of erectile function post-surgery vs. taldalafil alone

A very small (pilot scale), randomized, clinical trial has provided some evidence that combining the use of a vacuum erection device (VED) with taldalafil (Cialis) drug therapy after bilateral, nerve-sparing robot-assisted laparoscopic prostatectomy (BNS-RALP) can improve the probability of return of erectile function post-surgery. … READ MORE …

New “nerve sparing score” predicts post-surgical erectile function

The prostate cancer research team at Memorial Sloan-Kettering Cancer Center (MSKCC) has proposed and tested a new means for categorizing the amount of “damage” to the cavernous nerves as a method of predicting preservation of erectile  function after radical prostatectomy. … READ MORE …

AUA report and update no. 12: Friday, May 1, 2009

And still the stream of information continues, with  reports about frequency of PSA testing, nerve-sparing in men with Gleason 6 disease, and HIFU as a form of salvage therapy after first-line radiation: … READ MORE …

Additional news reports: Friday, January 16, 2009

In addition to the comments below about review articles on conservative therapy for low-risk, localized disease and eligibility of patients for focal therapy, there are some much more technical reports today on:

  • Appropriate use of differing types of biopsy to predict potential for nerve-sparing surgery
  • The hypothesis that oxidative stress may be related to risk for prostate cancer
  • The role of neuroendocrine cell differentiation in development of prostate cancer … READ MORE …